Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Still 437 million on the bid probably its 900 million because people waiting to put in buy orders at 2.
lol,even when the stock moved to 8 few weeks ago,you still were negative posting.So explain me your sense to be here if this is the biggest scam you are posting about on this NECA board?
Yes,I am already long here,not one positive post...
Then why my 2's dont get filled,LOL?
Only 445million bidsitters,LOL
No dilution,so how it will get covered?
This will go back higher!No doubt 3's are the cheapest for big loading volume
The waiting will be paid off big...
This is a perfect loading zone,to average down or to step in.I think with some positive signs in the 10K we saw the bottom.
LEAS remembers me of the run PKG* made.From nothing KABOOM!!We have a smaller float and AS.So anything is possible here!
The only thing whats wrong is to start short it now.Don't undertstand the sense to lie,if we had a +300million on friday that came from nowhere...SOMETHING BIG IS COMING.
The way is ran friday fast into the 5's was a sign the ask is thin...AS update....big things to come here...its loading time!!
Because he missed the train and thinks he can load 1's again.
RM or Buyout is coming,no RS
Yes,time to move north!
Where are the 3's LOL.Nothing nada,nothing,blabalahhh
Like the last run,LOL
The fact is the stock didn't see 2's or 1's.It went in fact to 8.
So?Wrong again.
.in the mean time there is zero verification for anything he has claimed;And why you here?LOL
5-Bagger even without news....
This stock can run without news...
BID growing,better to slap that ASK at 7....Before it will be at 8
Seems we saw the bottom here!!Time to move north again!
And what about oil dollars in the Middle-East...You think people from other countries can't open an account and buy SCIE??
HUGE POTENTIAL here and the big money will come in,its just the beginning for SCIE $$$
At these levels everything is a gift...The word SCIE will be spread from Europe over all continents.If every doctor will only buy some shares of SCIE we will be in pennyland even with this dilution!!
Huge buys coming in!!
Don't have to explain me...I am already some time in the stock.
We will going back north soon!Enjoy the ride up!
Still no 1's or 2's Levis?lol
Will not be suprised if they will step also in the MJNA sector next year with a higher OTC tier and with approved financials as a holding company they will add more sectors no doubt about that.
Remember we are a holding company now...So alot of new things to come....
I agree!!
Time for higher levels soon here!!
Outdated technology,you are kidding right?
The first Wavstat4 was seen in the end of 2016 in german hospital.
Why to invest in SCIE --->SpectraScience Inc.
Do your own DD on the stock.
-The Company’s lead platform—the WavSTAT® Optical Biopsy System—is in the final stages of a multicenter, 1,200-patient European study and is poised to commence sales in Europe and potentially Saudi Arabia in 2016 and new markets in China and India during 2017.The Wavstat4 is currently already used in some hospitals in Germany,Spain and other European Union countries. The current WavSTAT4 product is initially targeted to the colorectal cancer screening market where recent colonoscopy guidelines have created opportunities for new, improved diagnostic technologies.
-Up to 80% of colorectal biopsies performed are estimated to be identified as normal, non-cancerous tissue. Replacing these invasive physical biopsies with an optical biopsy, as SpectraScience's WavSTAT4 does, reduces risks to patients and may lead to a healthcare cost savings of over $1 billion in the U.S. alone.Currently waiting FDA approval for the USA.
-WavSTAT4 has been designed for ease of integration into the current standard of care. It entails essentially the same process as how physicians screen for cancer today, and is compatible with existing endoscopes. SpectraScience merely adds a layer of diagnostic interpretation and confidence by notifying physicians that, at a particular tissue location, they do not need to take a physical biopsy that they otherwise might have performed.
-Tissue that WavSTAT4 finds to be precancerous or cancerous returns a red “suspect” icon. Unlike the traditional method of visual inspection, there is no ambiguity to the result and no need for physician interpretation.
SpectraScience is further evaluating the potential of its technology in an array of additional indications and using a combination of next-generation, light-based technologies. Clinical results have suggested potential for WavSTAT4 in bladder cancer as well as in other oncology areas. SpectraScience in particular views the esophageal screening market as an opportunity, as endoscopes are the typical diagnostic tool of choice for both colorectal and esophageal screening.
-SpectraScience’s patent portfolio in the field of optical methods to detect cancer, cancer precursors, and tissue abnormalities includes 34 U.S. utility patents, seven U.S. design patents, 25 foreign counterpart patents, and an exclusive license to the Massachusetts General Hospital’s optical forceps patent.
-SpectraScience Inc has signed a distribution agreement with Advanced Medical German Co. (AMG) in Kuwait to be its exclusive distributor in the Middle East in july 2016
Seems like this stock is ugly shorted!!This is the truth
Which truth?That they in Europe and only have an office in USA.
Last 3's going!
Ready to go!!!
Just took a bigger position here!!!$$$LEAS
Why to invest in SCIE --->SpectraScience Inc.
Do your own DD on the stock.
-The Company’s lead platform—the WavSTAT® Optical Biopsy System—is in the final stages of a multicenter, 1,200-patient European study and is poised to commence sales in Europe and potentially Saudi Arabia in 2016 and new markets in China and India during 2017.The Wavstat4 is currently already used in some hospitals in Germany,Spain and other European Union countries. The current WavSTAT4 product is initially targeted to the colorectal cancer screening market where recent colonoscopy guidelines have created opportunities for new, improved diagnostic technologies.
-Up to 80% of colorectal biopsies performed are estimated to be identified as normal, non-cancerous tissue. Replacing these invasive physical biopsies with an optical biopsy, as SpectraScience's WavSTAT4 does, reduces risks to patients and may lead to a healthcare cost savings of over $1 billion in the U.S. alone.Currently waiting FDA approval for the USA.
-WavSTAT4 has been designed for ease of integration into the current standard of care. It entails essentially the same process as how physicians screen for cancer today, and is compatible with existing endoscopes. SpectraScience merely adds a layer of diagnostic interpretation and confidence by notifying physicians that, at a particular tissue location, they do not need to take a physical biopsy that they otherwise might have performed.
-Tissue that WavSTAT4 finds to be precancerous or cancerous returns a red “suspect” icon. Unlike the traditional method of visual inspection, there is no ambiguity to the result and no need for physician interpretation.
SpectraScience is further evaluating the potential of its technology in an array of additional indications and using a combination of next-generation, light-based technologies. Clinical results have suggested potential for WavSTAT4 in bladder cancer as well as in other oncology areas. SpectraScience in particular views the esophageal screening market as an opportunity, as endoscopes are the typical diagnostic tool of choice for both colorectal and esophageal screening.
-SpectraScience’s patent portfolio in the field of optical methods to detect cancer, cancer precursors, and tissue abnormalities includes 34 U.S. utility patents, seven U.S. design patents, 25 foreign counterpart patents, and an exclusive license to the Massachusetts General Hospital’s optical forceps patent.
-SpectraScience Inc has signed a distribution agreement with Advanced Medical German Co. (AMG) in Kuwait to be its exclusive distributor in the Middle East in july 2016
Time to move north ...